Showing results (571-580 of 584) with videos related to
Sort By:
Pageof 59
The Lancet. Respiratory Medicine|April 12, 2021
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trialSanjay Ramakrishnan, Dan V Nicolau, Beverly Langford, et al.Targeted Oncology|November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON StudyRachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.The Journal of Allergy and Clinical Immunology|January 10, 2018
Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary diseasePatrick Mallia, Jessica Webber, Simren K Gill, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 10, 2019
Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus ReportAnne-Marie C Dingemans, Lizza E L Hendriks, Thierry Berghmans, et al.The Lancet. Oncology|August 1, 2024
Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trialYi-Long Wu, Valentina Guarneri, Pei Jye Voon, et al.Lancet (London, England)|August 13, 2021
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trialLy-Mee Yu, Mona Bafadhel, Jienchi Dorward, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|August 31, 2015
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPDAnta Ngkelo, Roland F Hoffmann, Andrew L Durham, et al.Nature Genetics|October 21, 2003
Positional cloning of a novel gene influencing asthma from chromosome 2q14Maxine Allen, Andrea Heinzmann, Emiko Noguchi, et al.Journal of Global Health|November 5, 2021
Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decadeDavies Adeloye, Dhiraj Agarwal, Peter J Barnes, et al.The European Respiratory Journal|April 28, 2017
A European Respiratory Society technical standard: exhaled biomarkers in lung diseaseIldiko Horváth, Peter J Barnes, Stelios Loukides, et al.Pageof 59